Please use this identifier to cite or link to this item:
doi:10.22028/D291-43561 | Title: | Real-World Experience of People with Hemophilia A Receiving Turoctocog Alfa Pegol (N8-GP): Results from a Patient Experience Survey |
| Author(s): | Eichler, Hermann Nagao, Azusa Waller, John Stuber, Alexander |
| Language: | English |
| Title: | Patient preference and adherence |
| Volume: | 17 |
| Publisher/Platform: | Dove Medical Press |
| Year of Publication: | 2023 |
| Free key words: | hemophilia A turoctocog alfa pegol patient preference real-world evidence patient satisfaction quality of life |
| DDC notations: | 610 Medicine and health |
| Publikation type: | Journal Article |
| Abstract: | Turoctocog alfa pegol (N8-GP) is an extended half-life recombinant factor VIII molecule used for the treatment of hemophilia A (HA). The purpose of this study was to investigate real-world experiences of patients with HA treated with N8-GP. |
| DOI of the first publication: | 10.2147/PPA.S394216 |
| URL of the first publication: | https://pmc.ncbi.nlm.nih.gov/articles/PMC10661914/ |
| Link to this record: | urn:nbn:de:bsz:291--ds-435615 hdl:20.500.11880/39030 http://dx.doi.org/10.22028/D291-43561 |
| ISSN: | 1177-889X |
| Date of registration: | 26-Nov-2024 |
| Faculty: | M - Medizinische Fakultät |
| Department: | M - Chirurgie |
| Professorship: | M - Prof. Dr. Hermann Eichler |
| Collections: | SciDok - Der Wissenschaftsserver der Universität des Saarlandes |
Files for this record:
| File | Description | Size | Format | |
|---|---|---|---|---|
| ppa-17-3001.pdf | 1,55 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License
